Hisun Pharmaceutical (Contract Manufacturing)
Taizhou, Zhejiang, China
Hybrid — also manufactures internal programs
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
✓ FDA Inspections (1)
○ Clinical Trials
○ SEC Filings
○ Press
○ EMA GMP
○ MHRA GMP
✓ HC GMP (15)
Quick Facts: Hisun Pharmaceutical (Contract Manufacturing)
- Signal Score
- Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
- Headquarters
- Taizhou, Zhejiang, China
- Website
- https://www.hisunusa.com/
- Modalities
- Small Molecule API, Oral Solid Dose, Sterile Injectables, Microbial Fermentation, Veterinary
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
About Hisun Pharmaceutical (Contract Manufacturing)
Hisun Pharmaceutical (Contract Manufacturing) makes its own pharmaceutical products and also offers contract development and manufacturing services. Capabilities: Small Molecule API, Oral Solid Dose, Sterile Injectables, Microbial Fermentation, Veterinary. 2 manufacturing sites registered with the U.S. FDA and Health Canada. Website: https://www.hisunusa.com/
Signal Score
Profiled, not yet scored.
Scores are published after regulatory evidence is attached and reviewed.
How scoring works
Hisun Pharmaceutical (Contract Manufacturing) FDA Inspection History
2024-06
NAI
VAI
OAI
| Date | Site | Type | Observations | Classification |
|---|---|---|---|---|
| 2024-06-21 |
Zhejiang Hisun Pharmaceutical Co., Ltd.
Taizhou
Company-level
|
Drug Quality Assurance | No | Voluntary Action Indicated (VAI) |
Source: FDA Data Dashboard · Retrieved Oct 31, 2026
Hiring Activity Beta
Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source:
public careers pages
· Checked Oct 30, 2026
Frequently Asked Questions About Hisun Pharmaceutical (Contract Manufacturing)
How many FDA inspections does Hisun Pharmaceutical (Contract Manufacturing) have on record?
CDMO Signal tracks 1 FDA inspection for Hisun Pharmaceutical (Contract Manufacturing), sourced from the FDA inspection database. See the full inspection history above.
Has Hisun Pharmaceutical (Contract Manufacturing) received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Hisun Pharmaceutical (Contract Manufacturing).
Does Hisun Pharmaceutical (Contract Manufacturing) have a CDMO Signal Score?
Not yet. Hisun Pharmaceutical (Contract Manufacturing) is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating Hisun Pharmaceutical (Contract Manufacturing) for a manufacturing program?
Use the free AI matchmaker to compare Hisun Pharmaceutical (Contract Manufacturing) against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
Similar CDMOs
Wisdom Pharmaceutical
Haimen, Jiangsu, China
Small Molecule API, Sterile Injectables, Oral Solid Dose, Topicals, Veterinary
Bayer Contract Manufacturing
Leverkusen, Germany
Oral Solid Dose, Non-sterile Liquids, Semi-solids & Liquids, Sterile Injectables, Lyophilization, Prefilled Syringes, Small Molecule API, High-Potency APIs, Microbial Fermentation
Qilu Animal Health
Jinan, Shandong, China
Veterinary, Small Molecule API, Sterile Injectables, Oral Liquids, Powders & Premixes, Vaccines
Yichang Humanwell Pharmaceutical
Yichang, Hubei, China
Controlled Substances, Sterile Injectables, Lyophilization, Oral Solid Dose, Softgels, Transdermal Patches, Small Molecule API
Viwit Pharmaceutical
Zaozhuang, Shandong, China
Small Molecule API, Intermediates, Oral Solid Dose, Sterile Injectables
Compare Hisun Pharmaceutical (Contract Manufacturing) with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.